Drug intelligence / Profile preview

Vicks

Development stage
Unknown
Lead developer
Procter & Gamble
Modality
Small Molecules
Administration
Oral, Inhalation
01

Overview

Vicks is a brand of over-the-counter (OTC) medicines, encompassing products such as inhalers, throat drops, and cough syrups. The brand's products were historically marketed globally (outside North America) through PGT Healthcare, a joint venture established in 2011 between Procter & Gamble and Teva Pharmaceutical Industries. This venture aimed to leverage Procter & Gamble's brand-building and marketing capabilities with Teva's manufacturing and distribution expertise to accelerate growth in the global consumer healthcare market. As part of the arrangement, Teva also became the sole manufacturer for the joint venture and for Procter & Gamble's North American OTC business, including investing in a manufacturing plant in Sanand, India, for Vicks products. The PGT Healthcare joint venture was mutually terminated on July 1, 2018, due to diverging strategic priorities, allowing both companies to reclaim their contributed assets and pursue independent OTC strategies.

Brand names
Vicks
02

Targets

ADRA1 (Alpha-1 adrenergic receptor family)

Beyond the preview

Go deeper on Vicks.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vicks.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call